{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:49:02Z","timestamp":1708015742316},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1093\/jalm\/jfaa086","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T19:10:22Z","timestamp":1590520222000},"page":"550-553","source":"Crossref","is-referenced-by-count":2,"title":["Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma"],"prefix":"10.1093","volume":"6","author":[{"given":"Nicholas A","family":"Vitanza","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA"},{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedieh","family":"Khalatbari","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Ermoian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Sarthy","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA"},{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M","family":"Lockwood","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington and Seattle Children\u2019s Hospital, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie L","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Laboratories, Seattle Children\u2019s Hospital, Seattle, WA"},{"name":"Department of Anatomic Pathology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E S","family":"Leary","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA"},{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"key":"2021030606030659900_jfaa086-B1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jmoldx.2013.08.004","article-title":"Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens","volume":"16","author":"Pritchard","year":"2014","journal-title":"J Mol Diagn"},{"key":"2021030606030659900_jfaa086-B2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","article-title":"Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group","volume":"73","author":"Janssens","year":"2017","journal-title":"Eur J Cancer"},{"key":"2021030606030659900_jfaa086-B3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro-Oncology"},{"key":"2021030606030659900_jfaa086-B4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2021030606030659900_jfaa086-B5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"2021030606030659900_jfaa086-B6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/neuonc\/now282","article-title":"A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study","volume":"19","author":"Banerjee","year":"2017","journal-title":"Neuro-oncology"},{"key":"2021030606030659900_jfaa086-B7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","article-title":"Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma","volume":"5","author":"Huang","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"2021030606030659900_jfaa086-B8","first-page":"11:","article-title":"Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer","author":"McDonald","year":"2019","journal-title":"Sci Transl Med"},{"key":"2021030606030659900_jfaa086-B9","doi-asserted-by":"crossref","first-page":"107492","DOI":"10.18632\/oncotarget.18182","article-title":"Correlation between MEK signature and Ras gene alteration in advanced gastric cancer","volume":"8","author":"Ahn","year":"2017","journal-title":"Oncotarget"},{"key":"2021030606030659900_jfaa086-B10","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/MPH.0000000000000806","article-title":"Concomitant use of panobinostat and reirradiation in progressive DIPG: report of 2 cases","volume":"39","author":"Wang","year":"2017","journal-title":"J Pediatr Hematol\/Oncol"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jalm\/advance-article-pdf\/doi\/10.1093\/jalm\/jfaa086\/33698451\/jfaa086.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/2\/550\/36419215\/jfaa086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/2\/550\/36419215\/jfaa086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T06:04:53Z","timestamp":1615010693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/6\/2\/550\/5899256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,30]]},"published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaa086","relation":{},"ISSN":["2576-9456","2475-7241"],"issn-type":[{"value":"2576-9456","type":"print"},{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,8,30]]}}}